Vistagen Therapeutics, Inc.
VTGN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001411685
No open-market purchases or sales by Vistagen Therapeutics, Inc. insiders were filed in the last 90 days; 48 institutions reported holding it in 13F filings for Q2 2026, worth $2.54M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Vistagen Therapeutics, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 51
- +3 vs. Q1 2025
- Shares held
- 15.5M
- −449.8K (−2.8%) vs. Q1 2025
- Total value
- $30.3M
- −$8.75M (−22.4%) vs. Q1 2025
- New holders
- 6
- 17 more added
- Sold out
- 3
- 12 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VTGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 48 | $2.54M |
| Q1 2026 | 56 | $8.12M |
| Q4 2025 | 55 | $8.84M |
| Q3 2025 | 58 | $81.8M |
| Q2 2025 | 51 | $30.3M |
| Q1 2025 | 48 | $39.0M |
| Q4 2024 | 54 | $44.9M |
| Q3 2024 | 47 | $45.3M |
| Q2 2024 | 43 | $56.3M |
| Q1 2024 | 42 | $90.8M |
| Q4 2023 | 46 | $90.0M |
| Q3 2023 | 34 | $15.7M |
| Q2 2023 | 33 | $1.82M |
| Q1 2023 | 83 | $4.79M |
| Q4 2022 | 86 | $4.15M |
| Q3 2022 | 93 | $9.13M |
| Q2 2022 | 112 | $122.1M |
| Q1 2022 | 116 | $167.8M |
| Q4 2021 | 106 | $269.2M |
| Q3 2021 | 105 | $360.2M |
| Q2 2021 | 101 | $389.0M |
| Q1 2021 | 74 | $225.2M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Vistagen Therapeutics, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Barclays PLC | 1 | $2 | 0.00% | 00.0% | Unchanged |
| Fairman Group, LLC | 29 | $58 | 0.00% | 00.0% | Unchanged |
| Jones Financial Companies LLLP | 114 | $225 | 0.00% | +34+42.5% | Added |
| SBI Securities Co., Ltd. | 288 | $576 | 0.00% | +2+0.7% | Added |
| BNP Paribas Arbitrage, SA | 478 | $956 | 0.00% | +7+1.5% | Added |
| CWM, LLC | 582 | $1.00K | 0.00% | −1,000−63.2% | Reduced |
| MAI Capital Management | 526 | $1.05K | 0.00% | −50−8.7% | Reduced |
| Performa Ltd (US), LLC | 1,000 | $2.00K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 3,378 | $6.76K | 0.00% | +2,701+399.0% | Added |
| Royal Bank of Canada | 3,297 | $7.00K | 0.00% | +2,386+261.9% | Added |
| Citigroup Inc | 3,539 | $7.08K | 0.00% | +3,536+117,866.7% | Added |
| Advisor Group Holdings, Inc. | 4,493 | $8.99K | 0.00% | −1,001−18.2% | Reduced |
| Raymond James Financial Inc | 6,410 | $12.8K | 0.00% | +6,410 | New |
| Group One Trading, L.P. | 7,142 | $14.3K | 0.00% | +1,573+28.2% | Added |
| Truvestments Capital LLC | 7,155 | $14.3K | 0.00% | +7,155 | New |
| Tower Research Capital LLC (TRC) | 7,721 | $15.4K | 0.00% | +7,721 | New |
| Morgan Stanley | 12,147 | $24.3K | 0.00% | −39,138−76.3% | Reduced |
| Kestra Advisory Services, LLC | 20,033 | $40.1K | 0.00% | 00.0% | Unchanged |
| HighTower Advisors, LLC | 20,828 | $41.7K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 22,536 | $45.0K | 0.00% | +20,134+838.2% | Added |
| UBS Group AG | 22,813 | $45.6K | 0.00% | −2,966−11.5% | Reduced |
| Virtu Financial LLC | 22,946 | $46.0K | 0.00% | +22,946 | New |
| Charles Schwab Investment Management Inc | 23,302 | $46.6K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 25,832 | $51.7K | 0.00% | +15,100+140.7% | Added |
| American Century Companies Inc | 31,063 | $62.1K | 0.00% | 00.0% | Unchanged |
| Marshall Wace, LLP | 34,638 | $69.3K | 0.00% | +34,638 | New |
| Renaissance Technologies LLC | 40,500 | $81.0K | 0.00% | +15,700+63.3% | Added |
| Dimensional Fund Advisors LP | 43,362 | $86.7K | 0.00% | +25,817+147.1% | Added |
| Northern Trust Corp | 48,093 | $96.2K | 0.00% | 00.0% | Unchanged |
| Blair William & Co | 85,866 | $171.7K | 0.00% | −15,000−14.9% | Reduced |
| Persistent Asset Partners Ltd | 86,819 | $173.6K | 0.15% | −34,832−28.6% | Reduced |
| Two Sigma Investments, LP | 89,451 | $178.9K | 0.00% | −23,056−20.5% | Reduced |
| Jane Street Group, LLC | 95,051 | $190.1K | 0.00% | +95,051 | New |
| State Street Corp | 96,858 | $193.7K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 115,368 | $230.7K | 0.00% | +50,587+78.1% | Added |
| BML Capital Management, LLC | 150,000 | $300.0K | 0.23% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 177,858 | $355.7K | 0.01% | 00.0% | Unchanged |
| AdvisorShares Investments LLC | 203,114 | $406.2K | 0.07% | +44,000+27.7% | Added |
| Almitas Capital LLC | 261,399 | $522.8K | 0.13% | +6,744+2.6% | Added |
| Geode Capital Management, LLC | 272,907 | $546.0K | 0.00% | +2,720+1.0% | Added |
| Diadema Partners LP | 403,922 | $807.8K | 0.50% | −162,053−28.6% | Reduced |
| BlackRock, Inc. | 416,889 | $833.8K | 0.00% | +551+0.1% | Added |
| ADAR1 Capital Management, LLC | 420,765 | $841.5K | 0.14% | 00.0% | Unchanged |
| Sphera Funds Management Ltd. | 447,939 | $895.9K | 0.23% | −342,611−43.3% | Reduced |
| Ikarian Capital, LLC | 601,703 | $1.20M | 0.40% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 748,862 | $1.50M | 0.00% | −2,014−0.3% | Reduced |
| Commodore Capital LP | 1,575,000 | $3.15M | 0.22% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,759,642 | $3.52M | 0.00% | −200,530−10.2% | Reduced |
| Nantahala Capital Management, LLC | 1,978,492 | $3.96M | 0.28% | 00.0% | Unchanged |
| StemPoint Capital LP | 2,413,254 | $4.12M | 1.33% | +46,700+2.0% | Added |
| TCG Crossover Management, LLC | 2,676,580 | $5.35M | 0.61% | 00.0% | Unchanged |
| Prosperity Wealth Management, Inc. | 0 | $0 | 0.00% | −27,600−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −10,088−100.0% | Sold out |
| SJS Investment Consulting Inc. | 0 | $0 | 0.00% | −100−100.0% | Sold out |